Preparation method and application of galactose yeast-like fermentation filtrate

By optimizing the activation of the white dime strain and the use of sugar-containing culture medium, a galactose yeast-like fermentation filtrate with high active ingredients was prepared, which solved the problem of single function of the existing product and achieved significant whitening and antioxidant and skin barrier repair effects. , suitable for a variety of skin care applications.

CN119081871APending Publication Date: 2024-12-06WUHU KESHIYUAN BIOTECHNOLOGY CO LTD
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202311288803.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2023-10-08
Publication Date
2024-12-06

AI Technical Summary

Technical Problem

Existing galactose yeast fermentation products have single functions in antioxidant and skin barrier repair, and it is difficult to find bacterial strains and suitable fermentation processes that can ferment and produce a variety of skin care effects.

Method used

The galactosomiae-like fermentation filtrate with high active ingredients was prepared by using specific sugar-containing culture medium, and by optimizing fermentation conditions such as temperature, time and oscillation speed, a galactosomiasis-like fermentation filtrate with high active ingredients was prepared and inactivated. and filter to obtain the filtrate.

Benefits of technology

Improve the quality of fermentation products, significantly improve the whitening, antioxidant, moisturizing and skin barrier repair effects, the DPPH clearance and hyaluronic acid inhibition rate of yeast fermentation filtrate are significantly improved, the product is gentle and not irritating, suitable for medical, cosmetic and cosmetic purposes .

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119081871A_ABST
    Figure CN119081871A_ABST
Patent Text Reader

Abstract

The invention provides a preparation method and application of galactose yeast-like fermentation filtrate. The preparation method comprises the specific steps of strain activation, inoculation, fermentation and post-treatment. The galactose yeast-like fermentation filtrate has excellent effects of whitening, resisting oxidation, tightening, relieving and repairing skin, the DPPH clearance rate of the yeast fermentation filtrate reaches 192 mg Vc / L, the hyaluronidase inhibition rate reaches 52%, and the galactose yeast-like fermentation filtrate is mild and non-irritant when applied to the skin, has good adaptability, and can be used for skin care. The compound can be used as an additive component in medical, cosmetic and cosmetic compositions. The invention also provides galactose-like yeast skin care essence containing the galactose yeast fermentation filtrate, and the galactose-like yeast skin care essence has excellent repairing, soothing, tightening and anti-wrinkle effects, is mild and non-irritant, and is suitable for various skins.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of microbial fermentation, and in particular to a preparation method and application of galactose yeast-like fermentation filtrate. Background Art

[0002] The epidermis is the outermost layer of the human body, in direct contact with the outside world. Epidermal cells are tightly bound together to form a physical barrier to resist external harmful chemicals or pathogens. The barrier and protective functions of the epidermis rely on the integrity of healthy skin, and key proteins related to the barrier function play an extremely important role, such as FLG filaggrin, TJ tight junction protein, LOR loricrin, etc. The aging and damage of the skin barrier will not only lead to skin problems such as scars, wrinkles, and oiliness, but also pose potential risks to human health.

[0003] The filtrate of the fermentation product of galactosyl yeast is a natural yeast extract that produces small molecules including vitamin B group, minerals, amino acids, etc. that are beneficial to skin care. It is a high-quality yeast essence used for skin care. It can balance oil, adjust the overall condition of the skin, and make the skin translucent during use.

[0004] Chinese patent CN115161207A discloses a preparation method of galactose yeast liquid, galactose yeast powder and its application in skin lightening and wrinkle reduction. The galactose yeast liquid uses zelan saccharide and galactose as nutrients, and is fermented by galactose yeast. The fermented liquid is treated to obtain galactose yeast liquid. The sugar components in the galactose yeast liquid are found to contain oligosaccharides and oligosaccharides from zelan, and the emulsion or paste formed by the galactose yeast liquid can significantly improve the moisture content, elasticity and wrinkles of the subjects' skin, and is suitable as a cosmetic raw material for skin lightening, moisturizing and wrinkle reduction. However, it has no antioxidant and skin barrier repair effects, and its functions are relatively single.

[0005] And because different bacterial strains have obvious differences in fermentation metabolism, finding bacterial strains that can ferment and produce safe bacteria with multiple skin care effects and developing suitable fermentation processes are still the current research focus. Summary of the invention

[0006] In view of the above problems, the present invention provides a method for preparing a galactose yeast-like fermentation filtrate, which specifically comprises the following steps:

[0007] S1. Activation of bacterial strains: inoculating the fermentation strains into activation medium for activation to obtain activated bacterial strains;

[0008] S2, inoculation: inoculating the activated bacteria into the fermentation medium for cultivation to obtain a fermentation seed solution;

[0009] S3, fermentation: inoculating the fermentation seed liquid into the fermentation medium, and fermenting to obtain a fermentation liquid;

[0010] S4, post-treatment: inactivating and filtering the fermentation liquid to obtain the galactose yeast-like fermentation filtrate.

[0011] Wherein, the activation culture medium is a PDA solid culture medium; and the fermentation strain is a Geotrichum candidum strain.

[0012] Preferably, the activation temperature of the bacteria in step S1 is 25-30° C., and the activation time is 40-50 hours.

[0013] More preferably, the activation temperature of the bacteria in step S1 is 28° C. and the activation time is 48 hours.

[0014] Preferably, the specific operation steps of the inoculation in step S2 are: picking a single colony, inoculating it into a PDA slant culture medium, and culturing it at 28-30°C for 45-50 hours; adding sterile physiological saline to the PDA slant culture medium, scraping the bacterial lawn, and sucking out the spore suspension; adding the spore suspension to the fermentation culture medium, and culturing it at 25-30°C and 160-200rpm for 20-26 hours to obtain the fermentation seed liquid.

[0015] Preferably, the PDA slant culture medium is 8 mL PDA culture medium, 15 mm*150 mm test tube, and the effective length of the slant is 4-6 cm.

[0016] Preferably, the sterile physiological saline is 4-6 mL.

[0017] Preferably, the volume of the fermentation medium is 180-220 ml.

[0018] Further preferably, the volume of the fermentation medium is 200 ml.

[0019] Preferably, the fermentation medium in step S2 is a sugar-containing medium.

[0020] In order to better provide a suitable growth environment for the culture of bacteria and effectively promote the secretion of active ingredients by bacteria, preferably, the preparation method of the sugar-containing culture medium is as follows:

[0021] (1) Mixing: Weigh 45-50g of rice and 8-11g of soybeans, mix and grind to 50-200 mesh; add 180-220ml of water and stir evenly;

[0022] (2) Enzymolysis: add 180-210 μL of high temperature amylase, heat to 90-100°C, and keep warm for 20-40 minutes; cool to 55-65°C, add 8-11 g of sea buckthorn juice, add acid solution to adjust the pH to 4-4.5, add 0.4-0.6 g of saccharifying enzyme, mix well and keep warm for 50-70 minutes; add alkaline solution to adjust the pH to 6.6-7, add 18-22 mg of papain, mix well and keep warm for 50-70 minutes to obtain an enzymolysis solution;

[0023] (3) Sterilization: After the enzymatic hydrolyzate is cooled to room temperature, water is added to dilute it and sterilize it to obtain the sugar-containing culture medium.

[0024] Preferably, the concentration of the high-temperature amylase is 20,000 U / mL; the concentration of the saccharifying enzyme is 100,000 U / g; and the concentration of the papain is 100,000 U / g.

[0025] Preferably, in the enzymatic hydrolysis step, the acid solution is a phosphoric acid solution; and the alkaline solution is a sodium hydroxide solution.

[0026] Further preferably, the concentration of the phosphoric acid solution is 1 mol / L, and the concentration of the sodium hydroxide solution is 5 mol / L.

[0027] Preferably, in the sterilization step, the water added is soft water at room temperature, and the total volume is 1 L; the sterilization is performed at 118-125° C. for 20-40 min.

[0028] The culture medium of the present invention is rich in nutrients such as small molecules, polysaccharides, natural oligosaccharides and vitamins, which provides a suitable growth environment for the fermentation culture of the strains, improves the fermentation efficiency of the strains, the yield of secondary metabolites, secretes more active ingredients, and further improves the quality of the fermentation products.

[0029] Further preferably, the preparation method of the sugar-containing culture medium is as follows:

[0030] (1) Mixing: Weigh 48.2 g of rice and 10 g of soybeans, mix and grind to 50-200 mesh; add 200 ml of water and stir evenly;

[0031] (2) Enzymolysis: add 200 μL of high-temperature amylase, mix well, heat in a water bath to 95°C, and keep warm for 30 minutes; cool to 60°C, add 10 g of sea buckthorn juice, add phosphoric acid to adjust the pH to 4.2, add 0.5 g of saccharifying enzyme, mix well, and keep warm for 60 minutes; add sodium hydroxide solution to adjust the pH to 6.8, add 20 mg of papain, mix well, and keep warm for 60 minutes to obtain an enzymolysis solution;

[0032] (3) Sterilization: After the enzymatic hydrolyzate is cooled to room temperature, soft water at room temperature is added to a total volume of 1 L, and sterilized at 121° C. for 30 min to obtain the sugar-containing culture medium.

[0033] Preferably, the specific steps of fermentation in step S3 are: inoculating the fermentation seed liquid into the fermentation medium at an inoculation rate of 10%, and culturing at 25-30° C. and 160-200 rpm with shaking for 65-75 hours.

[0034] Further preferably, the shaking culture time is 72 h.

[0035] According to the test results of free radical scavenging activity and hyaluronic acid inhibitory enzyme, the inventors found in the experiment that the galactose yeast fermentation filtrate obtained when the culture time is 65-75h is gentle to use, has the best content of active ingredients, and has the best whitening, anti-oxidation, moisturizing and repairing effects. The inventors analyzed that it may be because under this condition, the active ingredients secreted by the strains reach a peak value, thus having the best use effect. If the culture time is too short, the strain culture time is not enough, resulting in less secretion of active ingredients, and if the culture time is too long, the bacterial population density of the strain becomes larger, the nutrients are effective, and the growth pressure of the strain becomes larger, which is mainly because the survival of the strain cannot secrete active ingredients.

[0036] Preferably, the specific steps of post-treatment in step S4 are: inactivating the fermentation liquid at 70-90° C. for 8-15 min, filtering through gauze, plate-and-frame filter cloth, and qualitative filter paper to obtain a filtered liquid; that is, the galactose yeast-like fermentation filtrate is obtained.

[0037] Preferably, the method for preparing the galactose yeast-like fermentation filtrate specifically comprises the following steps:

[0038] S1. Activation of strains: inoculating the Geotrichum candidum strain into PDA solid culture medium for activation at a temperature of 25-30° C. for 40-50 h to obtain activated strains;

[0039] S2, inoculation: pick a single colony, streak it continuously onto a PDA slant medium, and culture it at 28-30°C for 45-50h; add 4-6mL of sterile physiological saline to the slant medium, scrape the bacterial lawn, and suck out the spore suspension; add the spore suspension to a fermentation medium with a liquid volume of 200mL, and culture it at 25-30°C and 160-200rpm for 20-26h to obtain the fermentation seed liquid;

[0040] S3, fermentation: inoculate the fermentation seed liquid into 200 mL of fermentation medium at an inoculation rate of 10%, and culture at 25-30°C and 160-200 rpm with shaking for 65-75 hours to obtain fermentation liquid;

[0041] S4, post-treatment: after inactivating the fermentation liquid at 70-90°C for 8-15 minutes, filter it through gauze, plate-and-frame filter cloth, and qualitative filter paper to obtain a filtered liquid; that is, the galactose yeast-like fermentation filtrate is obtained.

[0042] Another aspect of the present invention provides a use of galactose yeast-like fermentation filtrate in medical, cosmetic and cosmetic compositions.

[0043] A galactose-like yeast skin care essence containing the galactose yeast fermentation filtrate. The raw materials of the galactose-like yeast skin care essence include, by weight percentage: phase A: 0.1-1% preservative, 0.1-1% nano-ceramide liposome, 15-25% of the galactose yeast fermentation filtrate; phase B: 0.1-1% arginine, 10% water; phase C: 1-5% glycerol, 0.01-0.2% hydroxyethyl cellulose, 0.1-1% carbomer, and the balance water.

[0044] A method for preparing the above-mentioned galactose-like yeast skin care essence, the specific preparation steps are as follows:

[0045] Step S1: Heat phase B and phase C to 60-80°C respectively, and stir to dissolve;

[0046] Step S2: Add phase B to phase C and stir to dissolve evenly;

[0047] Step S3: Cool down to below 45° C., add phase A, and stir to dissolve evenly to obtain the galactose-like yeast skin care essence.

[0048] Compared with the prior art, the present invention has the following beneficial effects:

[0049] 1. The present invention induces the culture of bacterial strains to obtain a fermentation strain with higher growth efficiency, and uses a specific sugar-containing culture medium for fermentation culture, thereby improving the fermentation efficiency and secondary metabolite yield of the bacterial strains, secreting more active ingredients, and further improving the quality of the fermentation products.

[0050] 2. The galactose yeast-like fermentation filtrate of the present invention has excellent whitening, anti-oxidation, firming, soothing and skin repairing effects. The DPPH scavenging rate of the yeast fermentation filtrate reaches 192 mg Vc / L, and the hyaluronidase inhibition rate reaches 52%.

[0051] 3. The galactose yeast-like fermentation filtrate of the present invention is mild and non-irritating when applied to the skin, has stable physical and chemical indicators, is easy to store, is not prone to discoloration and deterioration, and has good adaptability, and can be used as an added ingredient in medical, beauty and cosmetic compositions.

[0052] 4. The galactose yeast skin care essence prepared from the galactose yeast fermentation filtrate prepared by the present invention has excellent repairing, soothing, firming and anti-wrinkle effects, is mild and non-irritating, and is suitable for use on all kinds of skin. BRIEF DESCRIPTION OF THE DRAWINGS

[0053] Figure 1 The standard curve for the DPPH free radical scavenging activity test of the galactose yeast fermentation supernatant of the present invention;

[0054] Figure 2 is the average value of the transepidermal water loss TEWL value at each time point before and after the use of the sample in Example 1 of the present invention;

[0055] Figure 3 is the change rate of the average value of the transepidermal water loss TEWL value at each time point before and after the use of the sample of Example 1 of the present invention;

[0056] Figure 4 is the average value of the hemoglobin EI value at each time point before and after the use of the sample in Example 1 of the present invention;

[0057] Figure 5 is the rate of change of the average hemoglobin EI value at each time point before and after the use of the sample in Example 1 of the present invention;

[0058] Figure 6 The average value of the lactic acid stinging score at each time point before and after using the sample of Example 1 of the present invention;

[0059] Figure 7 is the rate of change of the average lactic acid stinging score at each time point before and after using the sample of Example 1 of the present invention;

[0060] Figure 8 is the average value of the skin elasticity R2 value at each time point before and after using the sample of Example 1 of the present invention;

[0061] Fig. 9 It is the rate of change of the average value of skin elasticity R2 value at each time point before and after using the sample of Example 1 of the present invention. DETAILED DESCRIPTION

[0062] In order to make the purpose, technical solution and advantages of the present invention more clearly understood, the present invention is further described in detail below in conjunction with the embodiments. It should be noted that the following embodiments are further descriptions of the present invention, rather than limitations of the present invention.

[0063] Example

[0064] Example 1

[0065] On the one hand, this embodiment provides a method for preparing a galactose yeast-like fermentation filtrate, which specifically comprises the following steps:

[0066] S1. Activation of strains: inoculating the Geotrichum candidum strain (deposit number: CCTCC M 20221612) into PDA solid culture medium for activation at 28°C for 48 hours to obtain activated strains;

[0067] S2, inoculation: pick a single colony, streak and inoculate it into PDA slant medium (8mL PDA medium, 15mm*150mm test tube, effective length of slant 5cm), and culture it at 28℃ for 48h until the mycelium grows evenly and covers the slant; add 5mL sterile physiological saline to the slant medium, use a sterile spatula to scrape the bacterial lawn to fully release the spores on the bacterial lawn, and then suck out the spore suspension; add the spore suspension into the fermentation medium with a liquid volume of 200mL, and culture it at 28℃ and 180rpm for 24h to obtain the fermentation seed liquid;

[0068] S3, fermentation: inoculate the fermentation seed liquid into 200 mL of fermentation medium at an inoculation rate of 10% (i.e., inoculate 1 bottle of fermentation seed liquid into 10 bottles of fermentation medium), and culture at 28° C. and 180 rpm with shaking for 72 h to obtain fermentation liquid;

[0069] S4, post-treatment: after the fermentation liquid is inactivated at 80°C for 10 minutes, it is filtered through 8 layers of gauze, 420 mesh plate-frame filter cloth, and medium-speed qualitative filter paper to obtain a filtered liquid; that is, the galactose yeast-like fermentation filtrate is obtained.

[0070] The Geotrichum candidum strain was independently screened and genetically improved by the Chengdu Institute of Biology, Chinese Academy of Sciences, and the strain accession number is M20221612.

[0071] The fermentation medium in step S2 is a sugar-containing medium, and the preparation method of the sugar-containing medium is as follows:

[0072] (1) Mixing: Weigh 48.2 g of rice and 10 g of soybeans, mix and grind to 100 mesh; add 200 ml of room temperature soft water and stir evenly;

[0073] (2) Enzymolysis: add 200 μL of high-temperature amylase, mix well, heat in a water bath to 95°C, and keep warm for 30 minutes; cool to 60°C, add 10 g of sea buckthorn juice, add phosphoric acid solution to adjust the pH to 4.2, add 0.5 g of saccharifying enzyme, mix well, and keep warm for 60 minutes; add sodium hydroxide solution to adjust the pH to 6.8, add 20 mg of papain, mix well, and keep warm for 60 minutes to obtain an enzymolysis solution;

[0074] (3) Sterilization: After the enzymatic hydrolyzate is cooled to room temperature, soft water at room temperature is added to a total volume of 1 L, and sterilized at 121° C. for 30 min to obtain the sugar-containing culture medium.

[0075] The concentration of high temperature amylase is 20,000 U / mL; the concentration of saccharifying enzyme is 100,000 U / g; and the concentration of papain is 100,000 U / g.

[0076] Thermoamylase with CAS number 9000-90-2 was purchased from Xiasheng Enzyme Biotechnology Co., Ltd.; saccharifying enzyme was purchased from Angel Yeast Co., Ltd.; papain was purchased from Pangbo Bioengineering Co., Ltd.

[0077] In the enzymatic hydrolysis step, the concentration of the phosphoric acid solution is 1 mol / L; the concentration of the sodium hydroxide solution is 5 mol / L.

[0078] Example 2

[0079] On the one hand, this embodiment provides a method for preparing a galactose yeast-like fermentation filtrate, which specifically comprises the following steps:

[0080] S1. Activation of strains: inoculating the Geotrichum candidum strain into PDA solid culture medium for activation at a temperature of 30° C. for 50 h to obtain activated strains;

[0081] S2, inoculation: pick a single colony, streak and inoculate it into PDA slant medium (8mL PDA medium, 15mm*150mm test tube, effective length of slant 5cm), and culture it at 30℃ for 50h until the mycelium grows evenly and covers the slant; add 5mL sterile physiological saline to the slant medium, use a sterile spatula to scrape the bacterial lawn to fully release the spores on the bacterial lawn, and then suck out the spore suspension; add the spore suspension into 200mL fermentation medium, and culture it at 30℃ and 200rpm for 26h to obtain the fermentation seed liquid;

[0082] S3, fermentation: inoculate the fermentation seed liquid into 200 mL of fermentation medium at an inoculation rate of 10% (i.e., inoculate 1 bottle of fermentation seed liquid into 10 bottles of fermentation medium), and culture at 25° C. and 160 rpm with shaking for 75 h to obtain fermentation liquid;

[0083] S4, post-treatment: after the fermentation liquid is inactivated at 80°C for 10 minutes, it is filtered through 8 layers of gauze, 420 mesh plate-frame filter cloth, and medium-speed qualitative filter paper to obtain a filtered liquid; that is, the galactose yeast-like fermentation filtrate is obtained.

[0084] The method for obtaining the fermentation strain is the same as in Example 1.

[0085] The fermentation medium in step S2 is a sugar-containing medium, and the preparation method of the sugar-containing medium is the same as that in Example 1.

[0086] Example 3

[0087] On the one hand, this embodiment provides a method for preparing a galactose yeast-like fermentation filtrate, which specifically comprises the following steps:

[0088] S1. Activation of strains: inoculating the Geotrichum candidum strain into PDA solid culture medium for activation at a temperature of 25° C. for 40 h to obtain activated strains;

[0089] S2, inoculation: pick a single colony, streak and inoculate it into PDA slant medium (8mL PDA medium, 15mm*150mm test tube, effective length of slant 5cm), and culture it at 28℃ for 45h until the mycelium grows evenly and covers the slant; add 5mL sterile physiological saline to the slant medium, use a sterile spatula to scrape the bacterial lawn to fully release the spores on the bacterial lawn, and then suck out the spore suspension; add the spore suspension into 200mL fermentation medium, and culture it at 25℃ and 160rpm for 20h to obtain the fermentation seed liquid;

[0090] S3, fermentation: inoculate the fermentation seed liquid into 200 mL of fermentation medium at an inoculation rate of 10% (i.e., inoculate 1 bottle of fermentation seed liquid into 10 bottles of fermentation medium), and culture at 30° C. and 200 rpm with shaking for 65 h to obtain fermentation liquid;

[0091] S4, post-treatment: after the fermentation liquid is inactivated at 80°C for 10 minutes, it is filtered through 8 layers of gauze, 420 mesh plate-frame filter cloth, and medium-speed qualitative filter paper to obtain a filtered liquid; that is, the galactose yeast-like fermentation filtrate is obtained.

[0092] The method for obtaining the fermentation strain is the same as in Example 1.

[0093] The fermentation medium in step S2 is a sugar-containing medium, and the preparation method of the sugar-containing medium is the same as that in Example 1.

[0094] Example 4

[0095] On one hand, this embodiment provides a method for preparing galactose yeast-like fermentation filtrate, and the specific steps are the same as those in Example 1.

[0096] The difference from Example 1 is that the fermentation medium in step S2 is a sugar-containing medium, and the preparation method of the sugar-containing medium is as follows:

[0097] (1) Mixing: Weigh 48.2 g of rice and 10 g of soybeans, mix and grind to 100 mesh; add 200 ml of room temperature soft water and stir evenly;

[0098] (2) Enzymolysis: add 180 μL of high temperature amylase, mix well, heat in a water bath to 90°C, and keep warm for 20 min; cool to 55°C, add 8 g of sea buckthorn juice, add phosphoric acid solution to adjust the pH to 4, add 0.4 g of saccharifying enzyme, mix well, and keep warm for 50 min; add sodium hydroxide solution to adjust the pH to 6.6, add 18 mg of papain, mix well, and keep warm for 50 min to obtain an enzymolysis solution;

[0099] (3) Sterilization: After the enzymatic hydrolyzate is cooled to room temperature, soft water at room temperature is added to a total volume of 1 L, and sterilized at 121° C. for 30 min to obtain the sugar-containing culture medium.

[0100] The specific raw materials of the sugar-containing culture medium are the same as those in Example 1.

[0101] Example 5

[0102] On one hand, this embodiment provides a method for preparing galactose yeast-like fermentation filtrate, and the specific steps are the same as those in Example 1.

[0103] The fermentation medium in step S2 is a sugar-containing medium, and the preparation method of the sugar-containing medium is as follows:

[0104] (1) Mixing: Weigh 48.2 g of rice and 10 g of soybeans, mix and grind to 100 mesh; add 200 ml of room temperature soft water and stir evenly;

[0105] (2) Enzymolysis: add 210 μL of high-temperature amylase, mix well, heat in a water bath to 100°C, and keep warm for 40 minutes; cool to 65°C, add 11 g of sea buckthorn juice, add phosphoric acid solution to adjust the pH to 4.5, add 0.6 g of saccharifying enzyme, mix well, and keep warm for 70 minutes; add sodium hydroxide solution to adjust the pH to 7, add 22 mg of papain, mix well, and keep warm for 70 minutes to obtain an enzymolysis solution;

[0106] (3) Sterilization: After the enzymatic hydrolyzate is cooled to room temperature, soft water at room temperature is added to a total volume of 1 L, and sterilized at 121° C. for 30 min to obtain the sugar-containing culture medium.

[0107] The specific raw materials of the sugar-containing culture medium are the same as those in Example 1.

[0108] Example 6

[0109] The present embodiment provides a galactose-like yeast skin care essence. The raw materials of the galactose-like yeast skin care essence include, by weight percentage: phase A: 0.5% preservative, 0.5% nano-ceramide liposome, 20% galactose yeast fermentation filtrate of Example 1; phase B: 0.5% arginine, 10% water; phase C: 3% glycerol, 0.1% hydroxyethyl cellulose, 0.4% carbomer, and the balance water.

[0110] A method for preparing the above-mentioned galactose-like yeast skin care essence, the specific preparation steps are as follows:

[0111] Step S1: Heat phase B and phase C to 70°C respectively, and stir to dissolve;

[0112] Step S2: Add phase B to phase C and stir to dissolve evenly;

[0113] Step S3: Cool down to below 45° C., add phase A, and stir to dissolve evenly to obtain the galactose-like yeast skin care essence.

[0114] Hydroxyethylcellulose, carbomer, arginine, and nanoceramide liposomes were purchased from Guangzhou Jucheng Chemical Co., Ltd. The preservative model was PROTECTOR GC-04, which was purchased from Guangzhou Jucheng Chemical Co., Ltd.

[0115] Comparative Example 1

[0116] On one hand, this embodiment provides a method for preparing a galactose yeast-like fermentation filtrate, and the specific steps are the same as those in Embodiment 1. The difference from Embodiment 1 is that in step S1, the activation temperature is 35°C and the activation time is 60 hours; in step S2, the inoculation culture is 35°C and the culture is 55 hours; the spore suspension is cultured at 35°C and 160 rpm for 26 hours; and in step S3, the fermentation is carried out at 35°C and 200 rpm with shaking for 72 hours.

[0117] Comparative Example 2

[0118] On one hand, this embodiment provides a method for preparing a galactose yeast-like fermentation filtrate, and the specific steps are the same as those of Embodiment 1. The difference from Embodiment 1 is that in step S3, the fermentation is carried out at 25° C. and 160 rpm with shaking for 80 h.

[0119] Comparative Example 3

[0120] On one hand, this embodiment provides a method for preparing galactose yeast-like fermentation filtrate, and the specific steps are the same as those of Example 1. The difference from Example 1 is that the sugar-containing culture medium is a commercially available tryptic soy agar culture medium purchased from Jinpin Chemical Technology (Shanghai) Co., Ltd.

[0121] Performance Testing

[0122] 1. DPPH free radical scavenging activity test:

[0123] The in vitro free radical scavenging activity of the galactose yeast fermentation supernatant and lysate was tested respectively, using the DPPH in vitro scavenging method as the test method:

[0124] ① Pipette 200 μL of the fermentation product into a 1.5 mL centrifuge tube, add 800 μL of anhydrous ethanol, mix thoroughly, and let it stand at 4°C for 1 hour;

[0125] ② Centrifuge at 12000g for 5 min, aspirate 800 μL of supernatant into a 5 mL centrifuge tube, add 2.4 mL of DPPH ethanol solution (51.3 mg / L), and stand at 25°C in the dark for 30 min to develop color;

[0126] ③ Prepare ascorbic acid standard solutions of different concentrations and replace the supernatant in ② for color development reaction;

[0127] ④ Measure the absorbance of each sample colorimetric solution at 518nm on a spectrophotometer and draw a standard curve based on the concentration of ascorbic acid solution-OD518nm (e.g. Figure 1 ), and the DPPH radical scavenging potency of each fermentation sample was calculated based on ascorbic acid.

[0128] 2. Hyaluronic acid inhibition rate

[0129] In general, allergic reactions are positively correlated with hyaluronidase activity, and compounds with hyaluronidase inhibitory activity often have strong anti-allergic ability. The in vitro anti-allergic performance test is performed using the Elson-Morgan hyaluronidase inhibition method. The specific implementation method of this test is as follows:

[0130] Reagent preparation:

[0131] Acetic acid solution: Measure 11.55 mL of glacial acetic acid and dilute to 1 L with water.

[0132] Sodium acetate solution: Weigh 16.4 g of anhydrous sodium acetate, dissolve it in water and make up to 1 L.

[0133] Sodium carbonate solution: Weigh 105.99 g of anhydrous sodium carbonate, dissolve it in water and make up to 1 L.

[0134] Calcium chloride solution: Weigh 277.45 g of calcium chloride, dissolve it in water and make up to 1 L.

[0135] Sodium hydroxide solution: Weigh 200g of sodium hydroxide, dissolve it in water and make up to 1L.

[0136] Acetate buffer (0.1M, pH 5.6): Measure 452 mL of acetic acid solution and 48 mL of sodium acetate solution, and make up to 1 L with water.

[0137] Sodium hyaluronate solution: Weigh 0.5 g of sodium hyaluronate, dissolve it in acetate buffer (0.1 M, pH 5.6) and make up to 1 L.

[0138] Hyaluronidase solution: Weigh 5000U hyaluronidase (extracted from bovine testicles) and dissolve it in 10mL acetate buffer (0.1M, pH5.6), i.e. 500U / mL enzyme solution, which is prepared and used immediately.

[0139] Acetylacetone solution: Measure 3.5 mL of acetylacetone and dissolve it in 50 mL of sodium carbonate solution. Prepare and use immediately.

[0140] p-Diaminobenzaldehyde colorimetric agent (P-DAB colorimetric agent): Weigh 0.8 g of p-diaminobenzaldehyde, dissolve it in 15 mL of concentrated hydrochloric acid (38%, w / v), add 15 mL of anhydrous ethanol, and mix well.

[0141] Hyaluronidase activity inhibition reaction:

[0142] Take 4 10mL colorimetric tubes, number them A, B, C, and D respectively, add 0.5mL of the sample solution to be tested to A and B respectively; add 0.5mL of pure water to C and D respectively; add 0.5mL of hyaluronidase solution to A and C respectively; add 0.5mL of acetate buffer (0.1M, pH5.6) to B and D respectively, mix well, and incubate in a 37℃ water bath for 20min. Add 0.1mL of calcium chloride solution to each colorimetric tube, mix well, and incubate in a 37℃ water bath for 20min.

[0143] Hyaluronic acid hydrolysis reaction:

[0144] Add 0.5 mL of sodium hyaluronate solution to each of the above colorimetric tubes A and C, and add 0.5 mL of acetate buffer (0.1 M, pH 5.6) to each of B and D. After mixing evenly, incubate in a 37°C water bath for 40 min, and then place at room temperature for 10 min.

[0145] P-DAB color reaction:

[0146] Add 0.5 mL of pure water, 0.1 mL of sodium hydroxide solution, and 0.5 mL of acetylacetone solution to each colorimetric tube, mix well, heat in a boiling water bath for 15 min, cool in an ice bath for 10 min, and place at room temperature for 10 min. Add 1 mL of P-DAB color developer, mix well, add anhydrous ethanol to a total volume of 8 mL, mix again, and place at room temperature for 30 min to develop color. Measure the absorbance of the solution in each colorimetric tube at 530 nm, and count them as A, B, C, and D respectively. The hyaluronidase inhibition rate of the corresponding sample (Group A) is calculated according to the following formula:

[0147]

[0148] The galactose yeast-like fermentation filtrates of Examples 1-5 and Comparative Examples 1-3 were subjected to DPPH free radical scavenging activity test and hyaluronic acid inhibition rate test. The test results are shown in Table 1 below.

[0149] Table 1

[0150]

[0151]

[0152] 3. Repair, soothing, firming and anti-wrinkle efficacy tests

[0153] The galactose yeast skin care essence containing the galactose yeast fermentation filtrate of Example 6 was tested for repairing, soothing, firming and anti-wrinkle effects, and the test results are as follows.

[0154] Test items:

[0155] (1) Repair: Test method for the effect of cosmetics on transepidermal water loss (T / ZHCA003-2018), measuring the transepidermal water loss TEWL value ( TM 300), heme EI ( MX18);

[0156] (2) Soothing: Clinical evaluation standard for soothing functional skin care products (T / CNMIA0015-2020), measuring the lactic acid stinging score;

[0157] (3) Firming: Test method for firming efficacy of cosmetics (T / TDCA003-2021), measuring R2 value (Cutometer);

[0158] (4) Anti-wrinkle: Test method for anti-wrinkle efficacy of cosmetics (T / ZHCA006-2019), measuring the average depth of fine lines under the eyes, the average width of fine lines at the nasolabial folds, the average depth of fine lines at the nasolabial folds, the volume of fine lines at the outer canthus, and the average depth of fine lines at the outer canthus (Antera 3D);

[0159] (5) Gentle and non-irritating: Questionnaire.

[0160] Test method:

[0161] 31 subjects were selected, whose skin was dry and whose outer corners of the eyes were rated as grade 2 or above. No cosmetics, skin care products, beauty instruments and all external medicines should be used on the test areas within 1 day before the test. The facial skin used the sample "Galactosyl Yeast Skin Care Essence (Standard Sample)"; the subjects used the test sample twice a day, once in the morning and once in the evening after cleansing, for 4 consecutive weeks. Before use, after 2 weeks of use, and after 4 weeks of use, the subjects' faces were tested for transepidermal water loss TEWL value, hemoglobin EI value, skin elasticity parameter (R2), average depth of fine lines under the eyes, average width of nasolabial folds, average depth of nasolabial folds, volume of fine lines at the outer corners of the eyes, average depth of fine lines at the outer corners of the eyes, and average depth of fine lines on the forehead, and a questionnaire was filled out after the 4th week of testing.

[0162] (1) Repair test results

[0163] According to Table 2, Table 3, Figure 2 , Figure 3 The data show that the TEWL value shows a decreasing trend, and the TEWL value decreases by 15.38%, which is significantly different from before use (P < 0.001). The lower the value of TEWL, the better the skin barrier function.

[0164] Table 2 Descriptive statistics of transepidermal water loss TEWL values ​​(n=31)

[0165]

[0166] Note: ① Normality test P value>0.05, indicating that the data obeys normal distribution, paired t test is used. If it does not obey normal distribution, non-parametric rank sum test is used.

[0167] Table 3 Average values ​​and statistical results of transepidermal water loss TEWL values ​​before and after using the samples (n=31)

[0168]

[0169] Note: ② A significant P value of <0.05 indicates a significant difference compared with the control group or before use, indicated by "*"; a P value of <0.01 is indicated by "**"; a P value of <0.001 is indicated by "***". A significant P value of ≥0.05 indicates no significant difference compared with the control group or before use, indicated by "-".

[0170] According to Table 4, Table 5, Figure 4 , Figure 5 The data showed that the hemoglobin EI value showed a decreasing trend, and the hemoglobin EI value decreased by 3.75%, which was significantly different from before use (P < 0.05).

[0171] Table 4 Descriptive statistics of hemoglobin EI values ​​(n=31)

[0172]

[0173] Note: ① Normality test P value>0.05, indicating that the data obeys normal distribution, paired t test is used. If it does not obey normal distribution, non-parametric rank sum test is used.

[0174] Table 5 Average values ​​and statistical results of hemoglobin EI values ​​before and after using samples (n=31)

[0175]

[0176] Note: ② A significant P value of <0.05 indicates a significant difference compared with the control group or before use, indicated by "*"; a P value of <0.01 is indicated by "**"; a P value of <0.001 is indicated by "***". A significant P value of ≥0.05 indicates no significant difference compared with the control group or before use, indicated by "-".

[0177] (2) Relief test results

[0178] According to Table 6, Table 7, Figure 6 , Figure 7 The data showed that the lactic acid stinging score showed a decreasing trend. After using the galactose yeast fermentation filtrate for 4 weeks, the lactic acid stinging score decreased by 47.62%, and the number of subjects with positive lactic acid test (score ≥ 3 points) decreased by 15 people, which was significantly different from before use (P < 0.001). The lower the lactic acid stinging score, the less irritating the state, and the sample has a soothing effect.

[0179] Table 6 Descriptive statistics of lactic acid stinging scores (n=31)

[0180]

[0181] Note: ① Normality test P value>0.05, indicating that the data obeys normal distribution, paired t test is used. If it does not obey normal distribution, non-parametric rank sum test is used.

[0182] Table 7 Average lactic acid stinging score and statistical results before and after using the samples (n=31)

[0183]

[0184] Note: ② A significant P value of <0.05 indicates a significant difference compared with the control group or before use, indicated by "*"; a P value of <0.01 is indicated by "**"; a P value of <0.001 is indicated by "***". A significant P value of ≥0.05 indicates no significant difference compared with the control group or before use, indicated by "-".

[0185] (3) Compactness test results

[0186] According to Table 8, Table 9, Figure 8 , Fig. 9 The data show that the skin elasticity R2 value shows an increasing trend, and the average R2 value increases by 2.60%, which is significantly different from before use (P < 0.001); after using the sample for 4 weeks, there is a significant difference between the sample side and the blank control side (P < 0.05). The increase in the measured value indicates that the skin elasticity is improved.

[0187] Table 8 Descriptive statistics of skin elasticity R2 value (n=31)

[0188]

[0189] Note: ① Normality test P value>0.05, indicating that the data obeys normal distribution, paired t test is used. If it does not obey normal distribution, non-parametric rank sum test is used.

[0190] Table 9 Average values ​​and statistical results of skin elasticity R2 values ​​before and after using the samples (n=31)

[0191]

[0192] Note: ② A significant P value of <0.05 indicates a significant difference compared with the control group or before use, indicated by "*"; a P value of <0.01 is indicated by "**"; a P value of <0.001 is indicated by "***". A significant P value of ≥0.05 indicates no significant difference compared with the control group or before use, indicated by "-".

[0193] (4) Anti-wrinkle test results

[0194] 1) The average depth of fine lines under the eyes showed a decreasing trend. The average depth of fine lines under the eyes decreased by 6.12%, which was significantly different from before use (P < 0.001); the decrease in the measured value indicated that the average depth of fine lines decreased.

[0195] 2) The average width of the nasolabial folds showed a decreasing trend, with the average width of the nasolabial folds decreasing by 4.03%, which was significantly different from before use (P < 0.05); the decrease in the measured value indicates that the average width of the fine lines has decreased.

[0196] 3) The average depth of nasolabial folds and fine lines showed a decreasing trend, with the average depth of nasolabial folds and fine lines decreasing by 9.56%, which was significantly different from before use (P < 0.001); after using galactose yeast fermentation filtrate for 4 weeks, there was a significant difference in the sample side compared with the blank control side (P < 0.01);

[0197] 4) The volume of fine lines at the outer canthus showed a decreasing trend, with the average volume of fine lines decreasing by 31.24%, which was significantly different from before use (P < 0.001); after using galactose yeast fermentation filtrate for 4 weeks, there was a significant difference in the sample side compared with the blank control side (P < 0.05); the decrease in the measured value indicates that the volume of fine lines has decreased.

[0198] 5) The average depth of fine lines at the outer corners of the eyes showed a decreasing trend, with the average depth of fine lines decreasing by 10.79%, which was significantly different from before use (P < 0.001);

[0199] 6) The average depth of forehead fine lines showed a decreasing trend, with the average depth of fine lines decreasing by 25.00%, which was significantly different from before use (P<0.05)

[0200] (5) Mild and non-irritating test results

[0201] By observing 31 subjects with sensitive skin aged 30-53 (29 females and 2 males), the potential possibility of the samples causing adverse reactions to human skin was evaluated after continuous use of the samples for 4 weeks under normal conditions: 31 subjects had no adverse reaction feedback, and no adverse reactions were observed after follow-up observations after 2 and 4 weeks of use. 93.55% of the 31 people agreed that the samples were mild and non-irritating. The test data is shown in Table 10.

[0202] Table 10 Results of skin feel and efficacy evaluation of subjects

[0203]

Claims

1. A method for preparing a galactose yeast-like fermentation filtrate, characterized in that: The specific steps include: S1. Activation of bacterial strains: inoculating the fermentation strains into activation medium for activation to obtain activated bacterial strains; S2, inoculation: inoculating the activated bacteria into the fermentation medium for cultivation to obtain a fermentation seed solution; S3, fermentation: inoculating the fermentation seed liquid into the fermentation medium, and fermenting to obtain a fermentation liquid; S4, post-treatment: inactivating and filtering the fermentation liquid to obtain the galactose yeast-like fermentation filtrate. Wherein, the activation culture medium is a PDA solid culture medium; and the fermentation strain is a Geotrichum candidum strain.

2. The method for preparing a galactose yeast-like fermentation filtrate according to claim 1, characterized in that: The activation temperature of the bacteria in step S1 is 25-30° C., and the activation time is 40-50 hours.

3. The method for preparing a galactose yeast-like fermentation filtrate according to claim 1, characterized in that: The specific operation steps of the inoculation in step S2 are: picking a single colony, inoculating it into a PDA slant culture medium, and culturing it at 28-30° C. for 45-50 hours; adding sterile physiological saline to the PDA slant culture medium, scraping the bacterial moss, and sucking out the spore suspension; adding the spore suspension to the fermentation culture medium, and culturing it at 25-30° C. and 160-200 rpm for 20-26 hours to obtain the fermentation seed liquid.

4. The method for preparing a galactose yeast-like fermentation filtrate according to claim 1, characterized in that: The fermentation medium in step S2 is a sugar-containing medium.

5. The method for preparing a galactose yeast-like fermentation filtrate according to claim 4, characterized in that: The preparation method of the sugar-containing culture medium is as follows: (1) Mixing: Weigh 45-50g of rice and 8-11g of soybeans, mix and grind to XX mesh; add 180-220ml of water and stir evenly; (2) Enzymolysis: add 180-210 μL of high temperature amylase, heat to 90-100°C, and keep warm for 20-40 minutes; cool to 55-65°C, add 8-11 g of sea buckthorn juice, add acid solution to adjust the pH to 4-4.5, add 0.4-0.6 g of saccharifying enzyme, mix well and keep warm for 50-70 minutes; add alkaline solution to adjust the pH to 6.6-7, add 18-22 mg of papain, mix well and keep warm for 50-70 minutes to obtain an enzymolysis solution; (3) Sterilization: After the enzymatic hydrolyzate is cooled to room temperature, water is added to dilute it and sterilize it to obtain the sugar-containing culture medium.

6. The method for preparing a galactose yeast-like fermentation filtrate according to claim 5, characterized in that: In the enzymatic hydrolysis step, the acid solution is phosphoric acid; and the alkaline solution is sodium hydroxide.

7. The method for preparing a galactose yeast-like fermentation filtrate according to claim 1, characterized in that: The specific steps of the fermentation in step S3 are: inoculating the fermentation seed liquid into the fermentation medium at an inoculation rate of 10%, and culturing at 25-30° C. and 160-200 rpm for 65-75 hours.

8. The method for preparing a galactose yeast-like fermentation filtrate according to claim 1, characterized in that: The specific steps of the post-treatment in step S4 are: after inactivating the fermentation liquid at 70-90° C. for 8-15 minutes, filtering it through gauze, plate-frame filter cloth, and qualitative filter paper to obtain a filtered liquid; that is, the galactose yeast-like fermentation filtrate is obtained.

9. Use of the galactosidase-like fermentation filtrate prepared by the method for preparing the galactosidase-like fermentation filtrate according to any one of claims 1 to 8 in medical, cosmetic and cosmetic compositions.

10. A galactose-like yeast skin care essence, characterized in that: By weight percentage, the raw materials include: Phase A: 0.1-1% preservative, 0.1-1% nanoceramide liposome, 15-25% of the above-mentioned galactose yeast fermentation filtrate; Phase B: 0.1-1% arginine, 10% water; Phase C: 1-5% glycerol, 0.01-0.2% hydroxyethyl cellulose, 0.1-1% carbomer, and the balance water.

Citation Information

Cited By

  • Multi-component composite composition with energy protection function and application thereof

    CN120189359A